|
⚲
|
| Keyboard |
| Avego Management LLC
✚
|
|
|---|---|
| CRD # | 310520 |
| SEC # | 801-120171 |
| CIK # | 0001886177 |
| AUM | 917.5 M (2026-03-31) |
| Employees | 16 (75% Investors, 0% Brokers) |
| Phone | 646-844-0030 |
| Address | 100 North Main Street Alpharetta, GA 30009 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Velan Capital Opportunity Fund II LLC | [2026-03-30] | 2.4 M | 1.8 M |
| Filed 2025-03-31 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Net Assets Decline to Disclose | ||||
| HF | Velan Horizon Fund LP | 2025-03-28 | 9.1 M | |
| PE | Ahc-II AGR Partners LP | [2024-03-28] | 29.5 M | |
| Filed 2023-05-12 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| HF | Velan Capital SPV I LLC | [2024-03-28] | 5.5 M | 18.1 M |
| Filed 2023-06-22 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| PE | Avego Healthcare Capital Fund II LP | [2023-03-31] | 278.1 M | 366.4 M |
| Filed 2023-10-12 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Commission $1,999,375 · Revenue Decline to Disclose | ||||
| HF | Velan Capital Master Fund LP | [2023-03-31] | 11.7 M | 256.1 M |
| Filed 2025-11-26 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| HF | Velan Capital Offshore Fund Ltd | [2023-03-31] | 11.7 M | |
| Filed 2025-11-26 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| VC | Avego Bioscience Capital LP | [2022-03-31] | 68.7 M | 92.4 M |
| Filed 2025-03-07 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| PE | Avego Healthcare Capital LP | [2020-12-16] | 109.4 M | 162.2 M |
| Filed 2024-11-15 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Commission $122,900 · Revenue Decline to Disclose | ||||
| HF | Velan Capital Partners LP | [2020-12-16] | 11.7 M | 143.9 M |
| Filed 2025-11-26 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| View All | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 9 | 917.5 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 9 | 917.5 |
| By Discretionary | ||
| Discretionary | 9 | 917.5 |
| Non-Discretionary | 0 | 0.0 |
| Total | 9 | 917.5 |
| By Non-United States Persons | ||
| Non-United States Persons | 256.1 | |
| United States Persons | 661.4 | |
| Total | 9 | 917.5 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Thomas Vandervort | Executive Officer | 6 | 2 | |
| James Flexner | Executive Officer | 4 | 2 | |
| Velan Capital Investment Management LP | Executive Officer | 3 | 1 | |
| Velan Capital Holdings LLC | Executive Officer | 3 | 1 | |
| Balaji Venkataraman | Executive Officer | 2 | 1 | |
| Avego Management LLC | Executive Officer | 2 | 1 | |
| Avego Healthcare Capital GP II LLC | Director | 2 | 1 | |
| Kevin McNeill | Executive Officer | 2 | 1 | |
| Avego Bioscience Capital GP LLC | Executive Officer | 1 | 1 | |
| Avego Healthcare Capital Holdings LLC | Executive Officer | 1 | 1 | |
| View All | ||||
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001886177] | |
| 4 | [0001886177] | |
| SC 13G | [0001886177] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| Avego Management LLC | Jasper Therapeutics Inc | [2021-10-04] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $0.3B |
| Serves | Institutional |
| Fund Types | Hedge Fund, Private Equity |
| LEI | 2549009SHB59XHUX6731 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Amplitude Healthcare Acquisition Corp JSPR
Common Stock, par value $0.0001 per share
|
2024-02-08 | Buy | 350,000 | $12.95 | 4,532,500 |
| Comparable Firms | State | AUM |
|---|---|---|
|
EOS Management LP
✚
|
NY | 957.1 M |
|
ThornTree Capital Partners LP
✚
|
MA | 955.3 M |
|
HCSF Management LLC
✚
|
NY | 949.4 M |
|
Dalal Street LLC
✚
|
TX | 936.3 M |
|
Toscafund Asset Management LLP
✚
|
933.3 M | |
|
Sandalwood Securities Inc
✚
|
NJ | 930.2 M |
|
Extract Advisors LLC
✚
|
CA | 914.4 M |
|
Yorkville Advisors Global LP
✚
|
NJ | 900.0 M |
|
Bow Street LLC
✚
|
NY | 884.7 M |
|
Sandglass Capital Advisors LLC
✚
|
NY | 873.7 M |